Lilly Just Placed Million Bet on Injectables Boom
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Indices fluctuate due to price swings in components and shifting sentiment. This short intro outlines the main causes of index volatility.
22,408 articlesLilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
As workers reassess early retirement, a dividend-heavy portfolio could substitute lost full-time income. This piece b...
Blue Origin plans a $10 billion round at a $130 billion valuation, backed by Jeff Bezos and institutional investors. ...
IBM slumped 22% in early trading on a preliminary Q2 miss, igniting a wider tech sector selloff as analysts weigh AI ...
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
A booming demand backdrop for chips collides with sky-high spending. This piece breaks down what Taiwan Semiconductor...
As the EV wave grows, two names stand out: Lucid and NIO. This guide weighs their momentum, finances, and risk, helpi...
Retail investors are increasingly offered access to private-market products as Wall Street courts Main Street. But ex...
February highlighted a split in space stocks: Iridium rose on stabilizing results, while Redwire and Spacemobile tumb...
Three utility ETFs are posting eye-catching gains as data-center demand grows, underscoring a new growth era for the ...
As market volatility persists in March 2026, traders are eyeing best stocks under $10 for potential gains. The group ...
Oklo rose 5% and NuScale Power gained 3% in early trading as investors renewed interest in nuclear energy stocks amid...